Paclitaxel/pembrolizumabLack of efficacy: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1918卷 / 1期

关键词：

D O I：

10.1007/s40278-022-20860-0

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：403 / 403

相关论文

共 50 条

[1] Carboplatin/paclitaxel/pembrolizumabLack of efficacy: case report
Reactions Weekly, 2022, 1894 (1) : 95 - 95
[2] Carboplatin/paclitaxel/pembrolizumabLack of efficacy: case report
Reactions Weekly, 2023, 1938 (1) : 369 - 369
[3] Cisplatin/paclitaxel/pembrolizumabLack of efficacy: case report
Reactions Weekly, 2025, 2042 (1) : 125 - 125
[4] Carboplatin/paclitaxel/pembrolizumabLack of efficacy and antibody syndrome: case report
Reactions Weekly, 2025, 2051 (1) : 82 - 82
[5] Paclitaxel/pembrolizumabLack of efficacy and pulmonary arterial hypertension: case report
Reactions Weekly, 2023, 1961 (1) : 335 - 335
[6] Paclitaxel/pembrolizumabLack of efficacy
Reactions Weekly, 2024, 2012 (1) : 294 - 294
[7] Paclitaxel/pembrolizumabLack of efficacy
Reactions Weekly, 2024, 2011 (1) : 346 - 346
[8] PembrolizumabLack of efficacy: case report
Reactions Weekly, 2022, 1895 (1) : 320 - 320
[9] PembrolizumabLack of efficacy: case report
Reactions Weekly, 2023, 1944 (1) : 473 - 473
[10] PembrolizumabLack of efficacy: case report
Reactions Weekly, 2022, 1922 (1) : 483 - 483

← 1 2 3 4 5 →